Chronic Fatigue Clinical Trial
Clinical Trial overview
EBOO Therapy for ME/CHF Symptoms
The team at the chronic fatigue clinic in Adelaide will be conducting ethical approved clinical studies.
The team will be led by Dr Andrew Lucas, a fellow of the Royal Australian College of General practitioners with an interest in chronic fatigue syndrome.
The clinical trial examines the effectiveness of extra Corporal ozonation, and oxygenation of blood on the symptoms of chronic fatigue syndrome.
Innovative Healthcare Research Foundation
Endorsed by the Innovative Healthcare Research Foundation Limited. Approved and overseen by the Bellberry Human Research Ethics Committee, and aligns seamlessly with the stringent standards set forth by the Therapeutic Goods Administration (TGA).
We extend an invitation to individuals within the age range of 18 to 75 with chronic fatigue. This encompasses a diverse spectrum, including those experiencing the lingering effects of long COVID, individuals affected by viral-induced fatigue, those enduring fatigue stemming from cancer-related treatments, as well as those navigating the challenges of fatigue linked to chronic infections.
We are committed to understanding and addressing the unique experiences of individuals across this wide spectrum of conditions.
Your participation holds the key to advancing our knowledge and improving the lives of those affected.
Inclusive Participant Search for ME/CHF Study
Revolutionizing ME/CHF Research with EBOO Therapy Advancements
Under the guidance of Dr. Andrew Lucas at the Chronic Fatigue Clinic in South Australia, this study presents a unique opportunity to evaluate the impact of a trial therapy on ME/CHF, an ailment currently without standardized treatment.
Participants undergo an initial eligibility assessment, followed by a meticulously observed six-month treatment phase to assess benefits and potential risks. Previous clinical trials featuring Extracorporeal Major Autohemotherapy (MAH) are accessible upon request.
This joint effort brings together esteemed Medical and Scientific Doctors from both national and international domains, dedicated to advancing ME/CHF research over several years. Together, we aim to ascertain if EBOO therapy can offer enduring relief for ME/CFS patients.
Funding for the study is facilitated through participant donations, corporate sponsorships, and grants. Specifics regarding funding will be thoroughly discussed with each participant either prior to or during their initial visit.